Versant Venture Capital VI L.P. 13D and 13G filings for Tempest Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-11 5:58 pm Unchanged | 2024-11-12 | 13D | Tempest Therapeutics, Inc. TPST | Versant Venture Capital VI L.P. | 162,973 4.800% | 0 (Unchanged) | Filing |
| 2024-08-12 8:59 pm Unchanged | 2024-08-08 | 13D | Tempest Therapeutics, Inc. TPST | Versant Venture Capital VI L.P. | 162,973 8.400% | 0 (Unchanged) | Filing |
| 2024-05-13 4:54 pm Unchanged | 2024-03-19 | 13D | Tempest Therapeutics, Inc. TPST | Versant Venture Capital VI L.P. | 162,973 9.500% | 0 (Unchanged) | Filing |
| 2024-02-08 5:41 pm Unchanged | 2023-11-08 | 13D | Tempest Therapeutics, Inc. TPST | Versant Venture Capital VI L.P. | 162,973 11.000% | 0 (Unchanged) | Filing |
| 2023-11-09 5:28 pm Unchanged | 2023-08-10 | 13D | Tempest Therapeutics, Inc. TPST | Versant Venture Capital VI L.P. | 162,973 15.900% | 0 (Unchanged) | Filing |
| 2022-05-09 5:26 pm Purchase | 2022-04-29 | 13D | Tempest Therapeutics, Inc. TPST | Versant Venture Capital VI L.P. | 162,973 20.500% | 72,321 (+79.78%) | Filing |
| 2022-02-10 7:41 pm Purchase | 2021-12-31 | 13G | Tempest Therapeutics, Inc. TPST | Versant Venture Capital VI L.P. | 90,652 17.100% | 90,652 (New Position) | Filing |